Fig. 1: p38α is a potential marker of therapy efficacy in stage III CRC patients.
A, B Kaplan–Meier curve of disease-free survival (DFS) (A) and progression-free survival (PFS) (B) in stage III CRC patients as a function of p38α levels.
Fig. 1: p38α is a potential marker of therapy efficacy in stage III CRC patients. | Cell Death & Disease
